What is Kalogon?
Kalogon specializes in the engineering and manufacturing of dynamic, medically-validated seating solutions designed to mitigate the long-term health risks associated with prolonged sitting. By integrating proprietary technology into products like the Orbiter Med and Booster, the company addresses critical needs in pressure management and ergonomic support. Their market position is defined by a dual focus on clinical efficacy and user-centric design, allowing them to bridge the gap between traditional medical equipment and high-performance consumer hardware. Through strategic partnerships with industry leaders, Kalogon is actively redefining standards for seated health across the aviation, automotive, and healthcare sectors.
How much funding has Kalogon raised?
Kalogon has raised a total of $13.2M across 3 funding rounds:
Angel/Seed
$4.5M
Unspecified
$5.8M
Private Equity
$2.9M
Angel/Seed (2024): $4.5M with participation from M7, venVelo, Sawmill Angels, Seedfundersorlando, and DeepWork Capital
Unspecified (2026): $5.8M led by Florida Opportunity Fund, DeepWork Capital, Black Opal Ventures, Enable Ventures, venVelo, Seedfunders, and Castellan Group
Private Equity (2026): $2.9M, investors not publicly disclosed
Key Investors in Kalogon
Enable Ventures
Enable Ventures is the first Impact Venture Fund focused on closing the disability wealth gap while achieving competitive, market-rate returns by scaling businesses that harness the economic potential of disability.
Black Opal Ventures
Black Opal Ventures is an investment firm that supports founders at the intersection of healthcare and technology, focusing on innovative solutions that address significant challenges in healthcare and security.
DeepWork Capital
DeepWork Capital invests professionally managed committed venture capital in growth-oriented early-stage companies in the technology and life science sectors, often taking a lead or co-lead role.
What's next for Kalogon?
With the successful closure of this major strategic investment, Kalogon is poised to transition from an early-stage innovator to an enterprise-level market leader. The company's roadmap focuses on the commercialization of its core technology, with plans to deepen its penetration into the medical device market while exploring new applications for its pressure-sensing platforms. By prioritizing research and development, Kalogon aims to solidify its intellectual property moat and expand its manufacturing capabilities to meet increasing demand. The involvement of specialized impact and venture funds suggests a long-term strategy centered on both financial scalability and the measurable improvement of quality-of-life outcomes for its user base.
See full Kalogon company page
